Literature DB >> 6184394

Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.

L F Lee, X Liu, R L Witter.   

Abstract

A total of 50 antibody-secreting hybridoma cells against Marek's disease virus (MDV) and turkey herpesvirus (HVT) have been produced. Eleven hybridomas were used for serotyping a panel of 15 pathogenic and nonpathogenic strains of MDV and HVT, representing three serotypes. The antibodies from the culture medium have fluorescence antibody (FA) titers of up to 100 and those from mouse ascitic fluid have titers ranging from 10(4) to 10(6). Monoclonal antibody T81 is type-common, i.e., it reacts at equal titer with all MDV and HVT tested. Of the remaining 10 antibodies, eight react only with pathogenic and attenuated strains of MDV (presumably serotype 1), one reacts only with nonpathogenic MDV (presumably) serotype 2), and one reacts only with strains of HVT (presumably serotype 3). Two hybridomas belong to IgG2a and IgG2b subclasses, respectively, and the remaining nine belong to IgG1 subclass. None of the antibodies specific for MDV strains reacted with homologous viruses in serum neutralization (SN), agar gel precipitin (AGP), or membrane immunofluorescence tests. Antibody L78, which is specific for HVT, was reactive with its homologous virus in the SN test; antibody from the culture medium showed an SN titer of 10 and that from mouse ascites a titer of 10,000. None of the antibodies specific for MDV or HVT reacted with other avian or mammalian herpesviruses, avian leukosis viruses (ALV), reticuloendotheliosis viruses (REV), or Marek's disease tumor-associated surface antigen (MATSA) expressed in a lymphoblastoid cell line, MDCC-MSB-1.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6184394

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.

Authors:  L F Lee; P Wu; D Sui; D Ren; J Kamil; H J Kung; R L Witter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  The Herpesviridae Conserved Multifunctional Infected-Cell Protein 27 (ICP27) Is Important but Not Required for Replication and Oncogenicity of Marek's Disease Alphaherpesvirus.

Authors:  Nagendraprabhu Ponnuraj; Yung-Tien Tien; Widaliz Vega-Rodriguez; Andrea Krieter; Keith W Jarosinski
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys.

Authors:  T Yamaguchi; S L Kaplan; P Wakenell; K A Schat
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication.

Authors:  Blanca Lupiani; Lucy F Lee; Xiaoping Cui; Isabel Gimeno; Amy Anderson; Robin W Morgan; Robert F Silva; Richard L Witter; Hsing-Jien Kung; Sanjay M Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

5.  Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens.

Authors:  Lucy F Lee; Xiaoping Cui; Zhizhong Cui; Isabel Gimeno; Blanca Lupiani; Sanjay M Reddy
Journal:  Virus Genes       Date:  2005-08       Impact factor: 2.332

6.  Marek's disease virus unique genes pp38 and pp24 are essential for transactivating the bi-directional promoters for the 1.8 kb mRNA transcripts.

Authors:  Jiabo Ding; Zhizhong Cui; Lucy F Lee
Journal:  Virus Genes       Date:  2007-07-06       Impact factor: 2.332

7.  Marek's disease virus phosphorylated polypeptide pp38 alters transcription rates of mitochondrial electron transport and oxidative phosphorylation genes.

Authors:  Michael S Piepenbrink; Xinhui Li; Priscilla H O'Connell; Karel A Schat
Journal:  Virus Genes       Date:  2009-05-27       Impact factor: 2.332

8.  Transformation of T-lymphocyte subsets by Marek's disease herpesvirus.

Authors:  K A Schat; C L Chen; B W Calnek; D Char
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency.

Authors:  Xiaoping Cui; Lucy F Lee; Willie M Reed; Hsing-Jien Kung; Sanjay M Reddy
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Deletion of 1.8-kb mRNA of Marek's disease virus decreases its replication ability but not oncogenicity.

Authors:  Aijun Sun; Yanpeng Li; Jingyan Wang; Shuai Su; Hongjun Chen; Hongfei Zhu; Jiabo Ding; Zhizhong Cui
Journal:  Virol J       Date:  2010-10-29       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.